$ROL

Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings - Rollins (NYSE:ROL)

Rollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.

Original reporting
Published Jul 24, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 1:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ROL
Bearish
high confidence
Mentioned
$ROL
Relevance
8/10
alphai data visualization · based on benzinga.com
Decision brief

The 30-second read

$ROLBearishMed
01

Why it matters

The earnings miss triggered immediate sell-side downgrades and substantial price-target reductions, reinforcing downside expectations.

02

Market read

Traders get a fresh earnings datapoint plus same-cycle analyst expectation resets, which can drive continued volatility beyond the initial reaction.

03

What to watch

The article does not include guidance, margin details, or management commentary, which could materially change the forward outlook despite the headline EPS and sales misses.

Relevance 8/10Novelty 6/10Timing: post-close Q2 earnings reaction, with pre-market analyst target cuts

Background

Rollins released Q2 results after the close, missing both EPS and revenue consensus.

Company-level read

Ticker impact

$ROLBearishHigh confidence
Context

Rollins reported Q2 EPS of 32 cents and sales of $1.079B, both below consensus, and shares fell pre-market.

Expected impact

Choppy to downside-biased trading likely persists as the market digests the earnings miss and revised analyst expectations.

Evidence & confidence

The article provides the specific EPS and sales misses, the pre-market drop, and two concrete downgrade plus price-target cuts (JPM and Wells Fargo).

Market effects

Limited sector read-through; this is primarily single-name earnings and sell-side expectation reset.

No specific regional spillover mentioned.

No global macro or cross-border catalyst cited.

Counterpoint

If the miss is driven by temporary timing or non-recurring items, the downgrades may overstate longer-term fundamentals.

Key entities

  • Rollins Inc

    Reported Q2 EPS of 32 cents vs 34 cents consensus and sales of $1.079B vs $1.092B consensus.

  • JP Morgan

    Downgraded Rollins from Overweight to Neutral and cut price target from $70 to $45.

  • Wells Fargo

    Downgraded Rollins from Equal-Weight to Underweight and cut price target from $46 to $32.

Related articles

$ROLMedAI 8/10

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

$ROLMed

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

$ROLMed

Wells Fargo says ditch this pest control stock as demand continues to soften

Wells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.

$ROLMed

Why Rollins Stock Is Plummeting Lower Today

Rollins (ROL) shares fell about 10% after the company reported Q2 results. Sales rose 8% and beat expectations, but adjusted EPS grew 7%, below forecasts. Organic sales increased 6%, with management guiding 6% full-year organic growth plus 2-3 points from acquisitions. Bank of America cut its price target to $35 from $55.